期刊文献+

RKIP在胆总管结扎肝纤维化大鼠肝脏组织的表达 被引量:5

Raf kinase inhibitor protein expression in liver of hepatic fibrosis rats induced by common bile duct ligation
下载PDF
导出
摘要 目的研究RKIP在胆总管结扎肝纤维化大鼠肝脏组织中的表达。方法SD大鼠60只,随机分为模型组(48只)、对照组(12只)。运用胆总管结扎方法制作大鼠肝纤维化模型,模型组分别于结扎后1、2、3、4w麻醉动物,假手术组与4w模型组同批麻醉,留取肝脏标本。组织切片经HE和Masson三色染色检测病理变化,Western印迹和免疫组织化学方法检测RKIP在肝组织的表达,用Western印迹方法检测RKIP和ERK的磷酸化水平。结果HE和Masson三色染色结果证明胆总管结扎大鼠肝纤维化模型制作成功。随着肝纤维化程度增高RKIP表达下降,RKIP和ERK的磷酸化水平则相应增加。结论胆总管结扎大鼠肝纤维化过程中肝脏组织Raf-1/MEK/ERK1,2信号转导途径的激活与RKIP的蛋白表达下降和磷酸化增加有关。 Objective To study Raf kinase inhibitor protein (RKIP) expression in liver of hepatic fibrosis rats induced by common bile duct ligation. Methods Hepatic fibrosis model was induced in Sprague-Dawley rats by common bile duct ligation (BDL). Livers in model group were harvested at 1, 2, 3 and 4 w after operation. Livers in sham operation group were harvested at 4 w after operation. Histopathological changes were evaluated by hematoxylin and eosin ( HE ) staining and by Masson' s trichrome method. RKIP expression and phosphorylation of RKIP and ERK in the livers were determined by Western blot, while the distribution of RKIP in the livers was assessed by immunohistoehemistry. Results HE and Masson's trichrome staining showed the successfully established hepatic fibrosis rats by common bile duet ligation. RKIP expression was decreased following the changes of hepatic fibrosis. On the contrary, phosphorylation of RKIP and ERK in the livers was increased. Conclusions The activation of Raf-1/MEK/ERK1,2 signaling pathway is correlated with decreased RKIP expression and increased phosphorylated RKIP in the livers of bile duct ligation rats.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2008年第20期1998-2000,共3页 Chinese Journal of Gerontology
基金 河北省自然科学基金资助项目(C2007000843)
关键词 RKIP ERK 肝纤维化 RKIP ERK Hepatic fibrosis
  • 相关文献

参考文献5

二级参考文献49

共引文献57

同被引文献39

  • 1Jiang, Ming-De,Zheng, Shu-Mei,Xu, Hui,Zeng, Wei-Zheng,Zhang, Yong,Sun, Hao-Ping,Wang, Yun-Xia,Qin, Jian-Ping,Wu, Xiao-Ling.An experimental study of extracellular signal-regulated kinase and its interventional treatments in hepatic fibrosis[J].Hepatobiliary & Pancreatic Diseases International,2008,7(1):51-57. 被引量:14
  • 2Nicholas TRAKUL,Marsha R. ROSNER.Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein[J].Cell Research,2005,15(1):19-23. 被引量:26
  • 3李龙,杨明正,周忠启,陈应强,曾家顺.阿托伐他汀对糖尿病大鼠肾脏保护作用及其机制探讨[J].中国病理生理杂志,2006,22(10):2059-2061. 被引量:15
  • 4Mora C,Navarro JF.The role of inflammation as pathogenic factor in the development of renal disease in diahetes. Curt Diab Rep, 2005, 5: 399-40l.
  • 5BemierI, Tresca JP, Jolles P. Ligand -binding studies with a 23kDa protein purified from bovine brain cytosol. Biochim Biophys Acta, 1986, 871: 19-23.
  • 6Jazirehi AR, Vega MI, Chatterjee D, et al. Inhibition of the Raf-MEK 1/2-ERK1/2signaling pathway. Bcl-xL down- regulation, and chemosensitization of non- Hodgkin ' s lymphoma B cells by fituximab. Cancer Res, 2004, 64: 7117-7126.
  • 7Brey MD, Bottinger E, Brosius FC, et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol, 2005, 16: 27-45.
  • 8Zeng L protein Imamoto (RKIP): therapeutic target A, Rosner MR. Raf kinase inhibitory a physiological regulator and future Expert Opin Ther Targets, 2008, 12: 1275-1287.
  • 9Dangi-Garimella S, Yun J, Eves EM, et al. Raf kinase inhibitory protein suppresses a metastasi-s signalling cascade involving LIN28 and let-7. EMBO J, 2009, 28: 347-358.
  • 10Karin M, Cao Y, Greten FR, et al. NF-KB in cancer: From innecent bystander to major c-ulprit. Nat Rev Cancer, 2002, 2: 301-310.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部